British artificial intelligence company Quantexia is evaluating a stock market listing in either the United Kingdom or the United States, potentially valuing the firm at several billion dollars.
Chief Executive Vishal Marria said the company has been prepared for an initial public offering since January and could proceed with a listing in the UK, the U.S., or both. Quantexia has not set a timeline for a public debut and may remain private indefinitely, Marria added.
The decision reflects broader trends in which London’s equity markets have lost listings to U.S. exchanges in recent years. Marria highlighted that the U.S. offers a larger pool of capital and the potential for higher valuations compared with the UK. A U.S. listing would mark another setback for London’s efforts to bolster its appeal as a destination for technology companies.
Quantexia, founded in 2016, develops AI software designed to help organizations process and analyze large datasets. Its technology is deployed by financial institutions, healthcare providers, and government agencies for applications such as fraud detection and financial crime prevention.
The deliberation comes as British policymakers urge public bodies to prioritize domestic technology providers over U.S. competitors. In July, UK Prime Minister Andy Burnham stated that Britain should leverage public procurement to support local industry, a move seen as an effort to counter reliance on firms like Palantir, whose data platform is used by the National Health Service.
A final decision on Quantexia’s listing plans has not been made, and the company continues to assess market conditions and strategic alternatives.
